Categoria: Articoli in lingua originale

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts

In a multicenter trial in Spain, we assigned 7447 participants (55 to 80 years of age, 57% women) who were at high cardiovascular risk, but with no cardiovascular disease at enrollment, to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed

Continua a leggere

Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced receipt of CE mark approval for the t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring (CGM) integration1. The Company plans to begin commercial sales of the pump

Continua a leggere

Artificial Pancreas Effective for Patients with Type 1 Diabetes

By Kelly Young Edited by Richard Saitz, MD, MPH, FACP, DFASAM   Artificial pancreases are associated with more time in a normal glycemic range for patients with type 1 diabetes, according to a meta-analysis in The BMJ. Researchers analyzed roughly 40 randomized trials of artificial pancreas versus other insulin treatments in 1000

Continua a leggere

FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the

Continua a leggere

Tandem Diabetes Care and Movi SpA Announce Agreement for Distribution of Insulin Pump Products in Italy

Tandem Diabetes Care®, Inc. (NASDAQ: tndm), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has entered into a distribution agreement with Movi SpA to commercialize Tandem’s t:slim X2™ Insulin Pump in Italy. “Partnering with experienced insulin pump

Continua a leggere
Skip to content